Introduction
============

Aging is an extremely complicated process and is known to be driven by a variety of different mutually interacting mechanisms. Conventionally, it is seen as a process of progressive failure of homeostasis involving genes for maintenance and repair, environmental factors leading to molecular damage and molecular heterogeneity, and chance events with potentially significant consequences for death ([@b2-cia-3-431]). Since several human progeroid synqdromes (PSs) (human premature aging-like syndromes) are characterized by features resembling precocious aging, the identification of the genes involved in PSs has provided important clues to understanding the molecular mechanisms underlying normal human aging ([@b75-cia-3-431], [@b54-cia-3-431]; [@b105-cia-3-431], [@b106-cia-3-431]).

The classic example of PS is Werner's syndrome (WS), a progeria of the adult, which is caused by a mutation in a gene coding for a member of the RecQ helicase family, *WRN* ([@b186-cia-3-431]) and is characterized by features resembling precocious aging, appearing as a variety of visible features associated with aging, such as graying of the hair and skeletal changes, which occur much earlier than normal ([@b59-cia-3-431]). WRN acts as a "caretaker of the genome" and functions in both DNA repair and transcription, suggesting that breakdown of these processes is critical in promoting aging ([@b46-cia-3-431]; [@b59-cia-3-431]; [@b5-cia-3-431]). Hutchinson-Gilford progeria syndrome (HGPS), a progeria of the child, is the other classic example, and is caused by mutations in the gene *LMNA* (1q21.2) ([@b48-cia-3-431]), encoding a nuclear envelope protein, lamin A, which has been shown to affect RNA polymerase II transcription, probably by alterations in chromatin organization ([@b107-cia-3-431]; [@b147-cia-3-431]; [@b70-cia-3-431]; [@b4-cia-3-431]). In addition, skin fibroblast biopsies from patients with HGPS fail to show evidence of normal DNA strand rejoining *in vitro* after exposure to irradiation, suggesting that DNA repair may be absent or greatly reduced in the cells ([@b47-cia-3-431]). Thus, these two PSs directly mimic the clinical and molecular features of natural aging, providing unique insights into the molecular mechanisms underlying human aging ([@b105-cia-3-431], [@b106-cia-3-431]). In this review, we will focus on these two best characterized PSs, with particular emphasis on the functions of the mutated syndrome-causing genes, and their potential implications for resemble aging. Based on the current information on these two syndromes, we also propose a model to explain human aging.

Werner's syndrome
=================

Werner's syndrome is a rare autosomal recessive disorder characterized by premature aging ([@b46-cia-3-431]; [@b103-cia-3-431]; [@b58-cia-3-431]; [@b186-cia-3-431]). The *WRN* gene responsible for WS encodes the 1432 amino acid WRN protein, which is a member of the RecQ DNA helicase family ([@b186-cia-3-431]). The C-terminal region of WRN contains the conserved RQC domain, which includes a nucleolar targeting sequence (NTS) ([@b102-cia-3-431]; [@b161-cia-3-431]), and the helicase and RNaseD C-terminal (HRDC) domain ([@b94-cia-3-431]). WRN has DNA-dependent ATPase, DNA strand annealing, DNA helicase, and exonuclease activities ([@b60-cia-3-431]; [@b151-cia-3-431], [@b152-cia-3-431]; [@b73-cia-3-431]). WRN, as a "caretaker of the genome", is needed to prevent telomere dysfunction and consequent genomic instability ([@b120-cia-3-431]; [@b37-cia-3-431]; [@b45-cia-3-431]). Since most of the mutations identified in *WRN* cause premature termination of translation ([@b59-cia-3-431]; [@b187-cia-3-431]), resulting in impaired nuclear import of the protein ([@b108-cia-3-431]), the clinical features and cellular phenotypes of WS patients are major due to an absolute lack of normal WRN in the nucleus. WS cells have defects in DNA replication, resulting in dysfunction in multiple cellular DNA metabolic processes, such as DNA replication initiation, replication foci establishment, and the resolution of stalled replication forks during replication and DNA repair ([@b103-cia-3-431]; [@b66-cia-3-431]). In addition, a large number of reports have shown that many cellular events, including transcription and apoptosis, are affected in WS cells ([@b116-cia-3-431]; [@b6-cia-3-431]; [@b148-cia-3-431], [@b149-cia-3-431]; [@b146-cia-3-431]). The loss of WRN function in WS appears as chromosome instability, a shorter life span in culture ([@b104-cia-3-431]), and accelerated telomere shortening ([@b137-cia-3-431]), suggesting that breakdown of WRN function is important in promoting aging ([@b103-cia-3-431]; [@b66-cia-3-431]).

Multiple functions of the WRN protein
=====================================

Biochemistry and catalytic activities
-------------------------------------

WRN, a multifunctional nuclear protein, interacts with a number of proteins to catalyze four major DNA-dependent enzymatic activities, acting (1) as a DNA-dependent ATPase, (2) as an intrinsic 3′→5′ helicase ([@b60-cia-3-431]), (3) as a 3′→5′ exonuclease ([@b73-cia-3-431], [@b74-cia-3-431]), and (4) in DNA strand annealing ([@b98-cia-3-431]), and interacts with factors with established roles in DNA metabolic pathways ([@b22-cia-3-431]). WRN contains three distinct structure-specific DNA-binding domains, one N-terminal domain and two different C-terminal fragments (the RecQ and HRDC domains), each of which plays roles in distinct DNA metabolic pathways ([@b163-cia-3-431]).

ATP-stimulated activities are required for the successive steps in the hydrolytic reaction, such as structure recognition, DNA binding, and 3′-terminal hydrolysis. In this context, WRN plays a DNA-dependent ATPase, using the energy from ATP hydrolysis to unwind double-stranded DNA, and its exonuclease and helicase activities act in concert to catalyze structure-dependent DNA degradation in resolving aberrant DNA structures ([@b142-cia-3-431]). As a helicase, WRN is active on the forked end of a DNA duplex, while, as an exonuclease, it acts on the blunt end of the same duplex ([@b60-cia-3-431]; [@b73-cia-3-431]; [@b118-cia-3-431]). WRN exonuclease can efficiently remove a mismatched nucleotide at a 3′ recessed terminus and can initiate DNA degradation from a 12-nucleotide gap or a nick ([@b74-cia-3-431]). Furthermore, WRN forms a trimer, which interacts with the proliferating cell nuclear antigen (PCNA) to participate in the replication restart process ([@b74-cia-3-431]; [@b130-cia-3-431]; [@b76-cia-3-431]). WRN exonuclease activity is suppressed by interaction with p53 ([@b19-cia-3-431]) or BLM ([@b162-cia-3-431]) and stimulated by interaction with Ku70/80 ([@b89-cia-3-431]) or phosphorylation ([@b80-cia-3-431]). WRN helicase activity is stimulated by interaction with replication protein A (RPA) ([@b141-cia-3-431]) or telomere repeat binding factor 2 (TRF2) ([@b119-cia-3-431]) and phosphorylation ([@b80-cia-3-431]). Moreover, WRN colocalizes and interacts with RAD52 and has strand annealing activity in addition to its DNA unwinding activity ([@b8-cia-3-431]; [@b98-cia-3-431], [@b99-cia-3-431]). WRN-dependent unwinding activity is significantly stronger than previously believed ([@b99-cia-3-431]).

Post-translational modifications
--------------------------------

In response to DNA damage, WRN can be modulated by post-translational modifications, including phosphorylation, sumoylation, and acetylation. It is phosphorylated at serine/threonine and tyrosine residues *in vivo* after bleomycin treatment or after replication stress ([@b80-cia-3-431]; [@b28-cia-3-431]; [@b124-cia-3-431]). WRN phosphorylation at serine/threonine residues is primarily dependent on DNA-PKcs and c-Abl kinases ([@b80-cia-3-431]; [@b28-cia-3-431]; [@b124-cia-3-431]). Importantly, the serine/threonine phosphorylation of WRN by the DNA-PK complex results in inhibition of both WRN helicase and exonuclease activities, whereas dephosphorylation of WRN enhances both these activities. Thus, the serine/threonine phosphorylation status of WRN plays a role in the regulation of its catalytic activities ([@b80-cia-3-431]; [@b28-cia-3-431]). c-Abl was also found to phosphorylate WRN ([@b28-cia-3-431]). c-Abl kinase, a regulator of the DNA damage response, mediates WRN nuclear localization and catalytic activities in response to DNA damage. WRN directly binds to c-Abl and this interaction is disrupted in the early cellular response to bleomycin ([@b28-cia-3-431]). As with phosphorylation by the DNA-PK complex, c-Abl phosphorylation inhibits WRN helicase and exonuclease activities ([@b28-cia-3-431]).

Phosphorylation of WRN may influence other forms of WRN post-translational modification, such as sumoylation and/or acetylation. Modification of proteins by the small ubiquitin-related modifier 1 (SUMO-1) conjugating system requires a set of enzymes, including SUMO-activating (E1), conjugating (Ubc9), and ligating enzymes ([@b113-cia-3-431]). WRN interacts with Ubc9, which is required for conjugation of SUMO-1 to the N-terminal fragment (amino acids 272--514) of WRN ([@b82-cia-3-431]). In addition, binding of p14 Arf to WRN is multivalent and resembles the binding of p14 Arf to Mdm2, promoting sumoylation of WRN in a synergistic manner with the SUMO-conjugating enzyme Ubc9 ([@b175-cia-3-431]). p14 Arf causes redistribution of WRN within the nucleus, and this effect is reversed by expression of a SUMO-specific protease, thus implicating the SUMO conjugation pathway in controlling WRN relocalization ([@b175-cia-3-431]). Besides phosphorylation and sumoylation, WRN can be acetylated after mitomycin C or methyl methane-sulfonate treatment ([@b140-cia-3-431]). On exposure to UV or ionizing radiation, WRN is acetylated by acetyltransferase p300, a transcriptional coactivator, which has acetylation activity ([@b13-cia-3-431]).

DNA replication
---------------

WRN helicase unwinds replication fork structures very efficiently ([@b111-cia-3-431]), acting to resolve the block and/or in the replication restart process ([@b130-cia-3-431]). Compared to normal cells, cells from WS patients undergo premature replicative senescence ([@b103-cia-3-431]; [@b133-cia-3-431]), display an extended S-phase ([@b125-cia-3-431]), and show a reduced frequency of replication initiation sites ([@b156-cia-3-431]; [@b63-cia-3-431]), thus exhibiting defects in DNA replication consistent with the inability to properly recover from DNA replication fork demise ([@b70-cia-3-431]).

WRN is able to interact with PCNA, DNA topoisomerase I (topo I), pol*δ,* and RPA ([@b174-cia-3-431]; [@b86-cia-3-431]; [@b17-cia-3-431]; [@b87-cia-3-431]; [@b33-cia-3-431]; [@b74-cia-3-431]; [@b84-cia-3-431]) and catalyze DNA unwinding *in vitro* for DNA replication, recombination, and repair ([@b22-cia-3-431]).

WRN and PCNA colocalize at replication foci, suggesting a physiological interaction between them in cycling primary cells ([@b130-cia-3-431]). In addition, WRN is as part of the 17S multiprotein DNA replication complex, and establishes PCNA and topoisomerase I as the two WRN-interacting components ([@b171-cia-3-431], [@b172-cia-3-431]; [@b87-cia-3-431]; [@b130-cia-3-431]).

Pol*δ* participates in DNA replication and repair of DNA damage. WRN interacts specifically with the p50 subunit of pol*δ*, and WRN directly modifies DNA replication via its interaction with p50 and is involved in the dynamic relocalization of pol*δ* complexes within the nucleus ([@b77-cia-3-431]; [@b154-cia-3-431]). Moreover, WRN enhances the rate of nucleotide incorporation in pol*δ-*mediated replication in the absence of PCNA and its helicase activity enables polδ to overcome hairpin and G-quadruplex DNA structures ([@b52-cia-3-431]; [@b154-cia-3-431]; [@b77-cia-3-431], [@b78-cia-3-431]; [@b20-cia-3-431]; [@b111-cia-3-431]). Thus, WRN may facilitate polδ-mediated DNA replication, and disruption of the WRN-polδ interaction in WS cells may contribute to the S-phase defects.

Human RPA is a heterotrimeric, single stranded DNA-binding protein required for DNA replication, recombination, and repair ([@b174-cia-3-431]; [@b17-cia-3-431], [@b23-cia-3-431]). RPA directly interacts with to WRN, markedly increasing the DNA helicase activity of WRN ([@b17-cia-3-431]; [@b143-cia-3-431]) and its ability to unwind forked telomeric DNA structures ([@b117-cia-3-431]; [@b118-cia-3-431]). After DNA damage, WRN can colocalize with BLM and RPA ([@b33-cia-3-431]; [@b12-cia-3-431]; [@b132-cia-3-431]). RPA binds to WRN and BLM to stimulate their unwinding of long DNA duplexes ([@b5-cia-3-431]).

Another interesting replication protein, FEN-1, interacts with the 144-amino acid RQC domain on the C-terminal region of WRN ([@b21-cia-3-431]). FEN-1, a DNA structure-specific nuclease, participates in pathways of DNA metabolism that are important for genomic stability ([@b22-cia-3-431]) and is involved in the maturation of Okazaki fragments during lagging strand DNA replication ([@b7-cia-3-431]; [@b110-cia-3-431]). WRN stimulates FEN-1-mediated cleavage activity of displaced flaps that occur during lagging strand DNA synthesis at Okazaki fragments ([@b21-cia-3-431]; [@b139-cia-3-431]). WRN-FEN-1 complex colocalizes in foci associated with arrested replication forks, and this complex plays a role in the unwinding and degradation of Holliday junction structures associated with regressed replication forks ([@b139-cia-3-431]). Defective Okazaki fragment processing causes DSBs, which may lead to the genomic instability in WS ([@b22-cia-3-431]).

WRN colocalizes with, and directly interacts with, human topo I ([@b84-cia-3-431]). WRN stimulates the ability of topo I to relax negatively supercoiled DNA and specifically stimulates the religation step of the relaxation reaction, and cell extracts from WS fibroblasts exhibit a decreased ability to unwind negatively supercoiled DNA ([@b84-cia-3-431]). These findings provide the interrelationship between WRN helicases and topoisomerases in the maintenance of genomic integrity.

DNA repair
----------

WS cells display sensitivity to 4-nitroquinoline 1-oxide ([@b116-cia-3-431]; [@b127-cia-3-431]), a carcinogen which causes the formation of DNA strand breaks and bulky DNA adducts ([@b114-cia-3-431]), and are also hypersensitive to O6-methylguanine, a site-specific alkylating agent that can block DNA replication ([@b14-cia-3-431]). WS cells are sensitive to DNA crosslinking drugs ([@b126-cia-3-431], [@b127-cia-3-431]) and, since DNA crosslinks are normally repaired by homologous repair (HR), this suggests a defect in this repair pathway. WS cells display extensive deletions at nonhomologous joined ends ([@b123-cia-3-431]; [@b27-cia-3-431]), while expression of wild-type WRN prevents excessive DNA deletions ([@b123-cia-3-431]; [@b27-cia-3-431]). These findings suggest that lack of WRN may increase DNA damage and disrupt the regulatory processes controlling DNA repair, for example, nonhomologous end joining (NHEJ), HR, and base excision repair (BER).

### Double-strand break repair

The first evidence for a link between WRN and double-strand break repair was the discovery that WRN interacts with both Ku and DNA-dependent protein kinase catalytic subunits (DNA-PKcs) ([@b34-cia-3-431]; [@b88-cia-3-431]; [@b28-cia-3-431]; [@b120-cia-3-431]) to participate in NHEJ ([@b90-cia-3-431]). Assembly of DNA-PK and WRN at DNA ends allows DNA-PKcs to phosphorylate WRN, thus stimulating WRN enzymatic activity and facilitating efficient processing of double-strand breaks (DSBs) prior to ligation ([@b183-cia-3-431]). Deficiencies in either Ku or DNA-PKcs result in sensitivity to ionizing radiation due to defects in DSB repair. Complementation with the exonuclease/helicase double mutant or wild-type WRN restores NHEJ activity, suggesting that WRN is necessary for normal repair of DSBs ([@b27-cia-3-431]).

Chromatographic studies showed that WRN is bound to PARP-1 in a complex that contains Ku70/80 ([@b91-cia-3-431]). PARP-1 can induce apoptosis or necrosis in cells with extensive DNA damage. Absence of functional WRN prevents activation of PARP-1 in response to DNA damage caused by oxidative stress and alkylating agents ([@b164-cia-3-431]).

Some proteins that participate in the recombinational repair pathway have been found to functionally interact with WRN. WRN is involved in resolving recombination intermediates in RAD51-dependent HR ([@b128-cia-3-431]; [@b131-cia-3-431]) and forms distinct nuclear foci that partially overlap with the RAD51 nuclear foci formed in response to DNA damage (including DSBs) ([@b132-cia-3-431]). *In vivo* data show that WRN interacts functionally with NBS1 ([@b29-cia-3-431]), which is thought to act downstream of RAD51 ([@b131-cia-3-431]; [@b157-cia-3-431]; [@b112-cia-3-431]). WRN colocalizes with, and interacts with, RAD52 ([@b8-cia-3-431]), NBS1 in the MRN complex ([@b29-cia-3-431]), and flap endonuclease 1 (FEN-1) ([@b21-cia-3-431]; [@b139-cia-3-431]). In addition, it interacts physically with the Mre11-RAD50-NBS1 complex, which also functions in HR for DSB processing ([@b29-cia-3-431]).

### Base excision repair

Oxidative DNA lesions are repaired primarily by base excision repair (BER), and the accumulation of oxidative products and the resulting phenotypic changes have been implicated in the aging process ([@b10-cia-3-431]). In general, BER can be divided into short patch repair and long patch repair. WRN has been shown to physically interacts with polβ and participate in short patch BER ([@b65-cia-3-431]). The active WRN helicase domain stimulates polβ strand displacement DNA synthesis at a nick on a BER substrate ([@b65-cia-3-431]). In addition, it has been shown to interact physically and/or functionally with several replication proteins which participate in long patch BER, including PCNA, RPA, polδ, and FEN-1 ([@b141-cia-3-431]; [@b17-cia-3-431], [@b23-cia-3-431]; [@b78-cia-3-431]). PCNA is part of a sliding clamp which forms a ring which maintains the connection between polymerase and its DNA template, allowing uninterrupted synthesis. WRN has been shown to directly interact with PCNA *in vitro*, suggesting a unique role for WRN in DNA synthesis ([@b74-cia-3-431]). WRN stimulates FEN-1 flap cleavage ([@b21-cia-3-431], [@b22-cia-3-431]) and nucleotide incorporation by polδ ([@b77-cia-3-431], [@b78-cia-3-431]). RPA stimulates WRN helicase unwinding of long substrates ([@b141-cia-3-431]; [@b17-cia-3-431]) and the poly(ADP-ribosyl)ation state of PARP-1 regulates WRN helicase and exonuclease activities ([@b165-cia-3-431]). PARP-1 binds strongly to strand breaks and acts in the DNA damage surveillance network, partly by ribosylating a variety of nuclear proteins in response to DNA damage.

DNA recombination
-----------------

Cellular DNA recombination can occur physiologically during meiotic DNA replication and V(D)J recombination, or can be induced by DNA damaging agents. Some reports define a physiological role for WRN RecQ helicase in recombination via RAD51-dependent HR ([@b128-cia-3-431]; [@b131-cia-3-431]). WRN and BLM colocalize to DNA damage-induced RAD51 foci, implicated in HR ([@b12-cia-3-431]; [@b132-cia-3-431]; [@b177-cia-3-431]; [@b131-cia-3-431]; [@b162-cia-3-431]; [@b178-cia-3-431]; [@b149-cia-3-431]). The WRN and BLM helicase activities are possible in a synergistic manner to intermediate DNA recombination, since a coimmunoprecipitation and colocalization study showed that the exonuclease domain of WRN interacts with BLM ([@b161-cia-3-431]). In addition, a biochemical study showed that WRN interacts with the homologous recombination mediator protein RAD52, and that WRN and RAD52 form a complex, should be a general response to replication forks arrested by DNA damage ([@b8-cia-3-431]).

WRN interacts physically and functionally with the MRN complex via NBS1 and they colocalize in response to ionizing radiation or mitomycin C treatment ([@b29-cia-3-431]). WS cells display a deficiency in resolving DNA recombination intermediates which contributes to DNA damage hypersensitivity, limited cell growth, and genomic instability ([@b128-cia-3-431]). The generation of viable mitotic recombinant progeny was rescued by the expression of WRN, which also improved WS cell survival after DNA damage ([@b131-cia-3-431]). These results define a physiological role for the WRN RecQ helicase protein in RAD51-dependent HR and identify a mechanistic link between defective recombination resolution and limited cell division potential, DNA damage hypersensitivity, and genetic instability in human somatic cells ([@b131-cia-3-431]). WRN also colocalizes with RAD51 and RPA in response to DNA damaging agents ([@b33-cia-3-431]; [@b132-cia-3-431]), and both WRN and BLM interact with RPA ([@b17-cia-3-431], [@b18-cia-3-431]).

Telomere maintenance
--------------------

Telomeres are specialized nucleoprotein structures consisting of G-rich repetitive sequences that cap the ends of eukaryotic chromosomes and are crucial for the maintenance of chromosomal integrity and cell viability ([@b109-cia-3-431]). They are maintained by the enzyme telomerase, which consists of an essential telomerase RNA component (TERC), which serves as a template for the addition of telomere repeats, and a protein component, the telomerase reverse transcriptase catalytic subunit (TERT). Telomere shortening eventually results in diverse pathophysiological consequences, primarily through accelerated telomere erosion, and triggers entry into premature senescence ([@b176-cia-3-431]; [@b15-cia-3-431]; [@b26-cia-3-431]; [@b45-cia-3-431]). Defects in telomere structure can initiate a DNA damage response and may lead to telomeric end fusions and chromosome breakage if not properly repaired ([@b43-cia-3-431]).

Biochemical and cellular evidence suggest that WRN may dissociate secondary structures at the telomere to allow replication, repair, and telomerase activity at the telomere end ([@b120-cia-3-431]). Under normal conditions, WRN associates with telomeres in S phase to prevent loss of individual telomeres ([@b37-cia-3-431]). Accelerated loss of telomere reserves and activation of cellular checkpoints appear integral to the decreased replicative potential seen in WS, as evidenced by the capacity of enforced TERT expression to impart unlimited replicative potential ([@b179-cia-3-431]).

WRN functionally interacts with a number of proteins involved in telomere length maintenance, including Ku 70/86 ([@b122-cia-3-431]), RPA ([@b17-cia-3-431], [@b18-cia-3-431]; [@b134-cia-3-431]), TRF1, and TRF2 ([@b119-cia-3-431], [@b121-cia-3-431]; [@b97-cia-3-431]). RPA is a single strand DNA-binding protein that is required for all aspects of DNA metabolism ([@b18-cia-3-431]), while TRF1 and TRF2 are homodimeric proteins that have been shown to bind exclusively to double stranded telomeric DNA throughout the cell cycle and are thought to be involved in the regulation of telomeric length ([@b49-cia-3-431]). TRF2 as a promoter for the helicase activity of WRN, the interaction between WRN and TRF2 may serve to stabilize TRF2 in its active form or to improve TRF2's interaction with DNA ([@b119-cia-3-431]). Due to the absence of WRN in WS patients, TRF2 is unable to perform its duty and telomeric-specific structures that need to be degraded are not ([@b61-cia-3-431]; [@b119-cia-3-431]; [@b76-cia-3-431]). These structures then act as barriers against various transcription factors and telomeres are left without being fully transcribed.

Taken together, these results suggest that WRN is necessary for the efficient replication of G-rich telomeric DNA and that *WRN* deficiency and dysfunctional telomeres appear to act cooperatively to increase the overall level of genomic instability, triggering the onset of premature aging phenotypes ([@b122-cia-3-431]; [@b119-cia-3-431], [@b121-cia-3-431]).

DNA apoptosis
-------------

A link between WRN and apoptosis was first proposed by studies demonstrating that WS fibroblasts exhibit a decreased p53- mediated apoptotic response, and this deficiency can be rescued by expression of wild-type *WRN* ([@b148-cia-3-431]). p53 is a key cellular component in maintaining genomic stability either by regulating the cell cycle to allow DNA repair or by inducing apoptosis ([@b68-cia-3-431]; [@b71-cia-3-431]; [@b85-cia-3-431]). The C-terminus of WRN binds to the C-terminal domain of p53 to induce p53-mediated apoptosis ([@b31-cia-3-431]; [@b153-cia-3-431]; [@b169-cia-3-431], [@b170-cia-3-431]; [@b148-cia-3-431]; [@b19-cia-3-431]).

Fibroblasts from WS patients have a decreased ability to undergo p53-mediated apoptosis ([@b148-cia-3-431]), so the absence of WRN-p53 direct interaction could serve as a signal for programmed cell death. Moreover, the expression of wild-type *WRN* is sufficient to rescue WS−/− cells from the attenuation of p53-mediated apoptosis ([@b148-cia-3-431]; Blander et al 2001). p53 may exert its effect on WRN by its interaction with RPA. Overexpression of p53 results in a decrease in Sp-1-mediated transcription of the *WRN* gene, suggesting that p53 regulates WRN expression ([@b180-cia-3-431]). Thus, the interaction of WRN with p53 and/or the WRN-RPA complex may be critical in preventing entry into S phase or in directing S phase cells towards apoptosis. The absence of a p53-WRN helicase interaction may disrupt the signal to direct S-phase cells into apoptosis for programmed cell death and contribute to the pronounced genomic instability and cancer predisposition seen in WS cells ([@b146-cia-3-431]). In addition, epigenetic inactivation (promoter hypermethylation) of WRN can lead to the loss of WRN-associated exonuclease activity and increased chromosomal instability and apoptosis induced by topoisomerase inhibitors ([@b1-cia-3-431]).

Hutchinson-Gilford progeria syndrome
====================================

Hutchinson-Gilford progeria syndrome, a childhood progeroid disorder, is a rare, fatal genetic disorder characterized by segmental accelerated aging. Affected children appear normal at birth, but within a year develop characteristic features of failure to thrive, delayed dentition, alopecia, atherosclerosis, prominent scalp veins, a high pitched voice, and sclerodermatous skin changes, with death at approximately 13 years from atherosclerosis of the coronary and cerebrovascular arteries. [@b48-cia-3-431] identified the disease causing mutations in the *LMNA* gene (encoding lamin A/C). The vast majority of HGPS cases are caused by a single-base substitution (GGC \> GGT), which does not cause an amino acid change (G608G), but results in deletion of 150 nucleotides in exon 11, causing an alternatively spliced truncated variant of lamin A mRNA and an in-frame deletion of 50 amino acids near the carboxy terminus, leading to changes in the nuclear architecture ([@b44-cia-3-431]; [@b48-cia-3-431]). Other HGPS mutations that have been described in *LMNA* include E145K, R471C, R527C, G608S, T623S, and 1824C \> T ([@b24-cia-3-431]; [@b38-cia-3-431]; [@b53-cia-3-431]). Lamins form microfilaments in the nucleus and are important in maintaining the proper structure of the nuclei, but they also influence on chromatin structure, regulation of gene expression, localization and probably protein degradation ([@b96-cia-3-431]; [@b56-cia-3-431]; [@b135-cia-3-431]). Immunofluorescence of HGPS fibroblasts with antibodies directed against lamin A revealed that many cells show visible abnormalities of the nuclear membrane ([@b48-cia-3-431]). In addition, HGPS cells have also altered histone modification patterns, including reduced heterochromatin-specific trimethylation of Lys^9^ on histone H3 (Tri-Me-K9H3) ([@b135-cia-3-431], [@b136-cia-3-431]). A recent study implicated lamin A in physiological aging, showing that the molecular mechanism responsible for the premature aging ([@b67-cia-3-431]; [@b136-cia-3-431]). Thus, accelerated aging in HGPS might thus reflect an exaggerated lamin A-dependent mechanism, which contributes to physiological aging.

Defects in prelamin A processing
--------------------------------

Lamin A has a conserved C-terminal CAAX motif, which is a potential target for subsequent processing steps. To generate mature lamin A, prelamin A undergoes substantial post-translational modification of its CAAX motif via four processing steps ([@b188-cia-3-431]; [@b185-cia-3-431]). First, a 15-carbon farnesyl lipid is added to the thiol group of the cysteine by a cytosolic enzyme, protein farnesyltransferase. Second, the last three amino acids of the protein (ie, the -AAX) are clipped off by the metalloprotease ZMP-STE24 and/or RCE1 ([@b11-cia-3-431]; [@b35-cia-3-431]). Third, the newly exposed farnesylcysteine is carboxylmethylated by ICMT, a prenylprotein-specific methyltransferase in the endoplasmic reticulum ([@b30-cia-3-431]; [@b42-cia-3-431]). Fourth, the last 15 amino acids of the protein, including the farnesylcysteine methyl ester, are clipped off by ZMPSTE24 and degraded, releasing mature lamin A ([@b173-cia-3-431]; [@b9-cia-3-431]; [@b35-cia-3-431]; [@b185-cia-3-431]). In HGPS, a 50-amino acid deletion in the C-terminus of the protein (amino acids 607--656) lacks an important endoprotease cleavage site recognized by ZMPSTE24 during prelamin A post-translational processing, so no mature lamin A is formed and a farnesylated mutant prelamin A (progerin) accumulates in cells ([@b44-cia-3-431]; [@b48-cia-3-431]; [@b115-cia-3-431]; [@b150-cia-3-431]; [@b159-cia-3-431]; [@b185-cia-3-431]).

Progerin accumulation and nuclear morphology abnormalities
----------------------------------------------------------

The mutant prelamin A is targeted to the nuclear rim, where it disrupts the integrity of the nuclear lamina, leading to premature cell death ([@b48-cia-3-431]; [@b57-cia-3-431]; [@b160-cia-3-431]; [@b181-cia-3-431]; [@b50-cia-3-431]). The GGC \> GGT (G608G) mutation of *LMNA* causes accumulation of farnesylprelamin A in the nucleus in a cellular age-dependent manner, and the cells display irregular nuclear shapes, including lobulation of the nuclear envelope, thickening of the nuclear lamina, loss of peripheral hetero-chromatin, and clustering of nuclear pores ([@b48-cia-3-431]; [@b57-cia-3-431]). Aberrant nuclear morphology is also reported with other LMNA mutations, which have been linked to other "laminopathies", such as Emery--Dreifuss muscular dystrophy, dilated cardiomyopathy-1A, Dunnigan-type familial partial lipodystrophy, mandibuloacral dysplasia, and atypical WS ([@b56-cia-3-431]; [@b27-cia-3-431]). In HGPS cells, the nuclei and lamina appeared normal at early passages, but, at later passages, the nuclei are severely misshapen and contain an abnormally thick lamina ([@b44-cia-3-431]; [@b48-cia-3-431]). These structural defects worsen as HGPS cells age in culture, and their severity correlates with an obvious increase in mutant lamin A ([@b57-cia-3-431]). An abnormal distribution of nuclear pore complexes is seen in late passage HGPS cells. The changes in nuclear pore complexes gradually affect various aspects of the normal trafficking of protein and RNA across the nuclear envelope, having severe effects on the physiological state of HGPS cells ([@b184-cia-3-431]). In addition, mutant lamin A induces decreased cellular proliferation, premature senescence, and altered motility ([@b57-cia-3-431]). The highly lobulated late passage HGPS cells primarily exhibit PCNA patterns resembling early S phase, suggesting that there is a block in the transition from the early chain-elongation phase of DNA replication to the mid- and later phases of replication. Mutant lamin A (progerin) progressively accumulates in the nucleus with cellular age, resulting in premature cessation of growth in the later passages of HGPS cells ([@b57-cia-3-431]).

Universal transcriptional alterations
-------------------------------------

Lamin A is a major constituent of the nuclear membrane, and an immunofluorescence study of HGPS fibroblast nuclei demonstrated abnormalities ([@b57-cia-3-431]). Given the prominent structural role of lamin A in the nuclear membrane, it is suggested that this protein has diverse roles in DNA metabolism, including DNA replication and transcription. Gene expression in HGPS was investigated by measuring mRNA levels in fibroblasts isolated from young, middle aged, and old humans with or without progeria ([@b96-cia-3-431]). Of the 152 genes studied, 47 (31%) were differentially transcribed in both old and HGPS compared to young. The direction of the change was the same in old and HGPS for all coregulated genes. Genes involved in mitosis were downregulated and the observed changes might result in increased rates of somatic mutation, leading to chromosome aberrations and mutations manifesting as an aging phenotype. [@b39-cia-3-431] found that the genes differentially expressed in HGPS fibroblasts compared to age-matched control cell lines are involved in a variety of biological processes. Of the approximately 33,000 genes analyzed, 361 (1.1%) showed at least a 2 fold change in HGPS compared to the aged controls. The most prominent categories encoded transcription factors and extracellular matrix proteins, many of which are known to function in the tissues severely affected in HGPS. The most affected gene was MEOX/GAX, a homeobox gene that functions as a negative regulator of proliferation. Several genes involved in DNA replication and chromatin remodeling were downregulated. These changes were interpreted as contributing to depression of cellular proliferation. Some of the transcription changes suggested excess extracellular matrix deposition through the increased expression of extracellular matrix components and decreased expression of extracellular matrix remodeling enzymes. Of the 58 genes examined by both of these groups, the expression of 17 (29%) changed in the same direction, demonstrating a reasonable agreement between the two studies considering their different designs. The studies by [@b83-cia-3-431] and [@b39-cia-3-431] point to a shared mechanism of aging acceleration in PSs ie, misregulated transcription. The idea that aging is due to the loss of the proper transcriptional state of the cell followed by "dysdifferentiation" had been previously proposed by other investigators ([@b81-cia-3-431]; [@b189-cia-3-431]; [@b51-cia-3-431]; [@b129-cia-3-431]). These findings that HGPS patients show inappropriate transcriptional patterns provides new evidence that transcriptional deregulation can contribute to the aging process in humans.

Genomic instability
-------------------

DNA damage accumulation and the effects of repair defects can lead to genomic instability associated with premature aging and have causal roles in normal aging ([@b95-cia-3-431]; [@b166-cia-3-431]). Indeed, defective recruitment of 53BP1 and RAD51 to sites of DNA lesion is seen in HGPS fibroblasts, resulting in a delayed checkpoint response and defective DNA repair ([@b92-cia-3-431]). Wild-type mouse embryonic fibroblasts ectopically expressing unprocessible prelamin A show similar defects in checkpoint response and DNA repair ([@b92-cia-3-431]). These results indicate that unprocessed prelamin A and truncated lamin A act dominant negatively to perturb the DNA damage response and repair, resulting in genomic instability, which might contribute to laminopathy-based premature aging ([@b92-cia-3-431]). In HGPS cells, DNA damage checkpoints are persistently activated, and inactivation of checkpoint kinases ATM and ATR can partially restore cell cycle progression into S-phase ([@b36-cia-3-431]; [@b93-cia-3-431]), suggesting that senescence can be suppressed by inactivating DNA damage response pathways in HGPS cells. Organismal aging has been linked to activation of p53-dependent signaling pathways and initiation of the senescence program in a premature aging mouse model ([@b160-cia-3-431]). Inhibition of aberrant splicing of lamin A results in significant downregulation of *p21, IGFBP3*, and *GADD45B* compared with mock-treated cells ([@b136-cia-3-431]). Consistent with the reduction in p53 activation, upon elimination of Δ50 lamin A from old cells, the fraction of 5-bromo-2′-deoxyuridine-positive proliferating cells increased by 30% and was similar to that in mock-treated young cells. Over the past few years, there have been reports that progerin leads to defective DNA repair and genome instability ([@b92-cia-3-431]), overexpression of p53 target genes ([@b160-cia-3-431]), and changes in histone methylation that affect heterochromatin organization ([@b144-cia-3-431]).

Farnesyltransferase inhibitor
-----------------------------

Farnesyl-prelamin A is targeted to the nuclear envelope, where it interferes with the integrity of the nuclear envelope and causes misshapen cell nuclei. It has also been shown to affect the mechanical stability of the nucleus ([@b41-cia-3-431]). Farnesyltransferase inhibitors (FTIs) can block prelamin A processing and reduce the percentage of cells with misshapen nuclei ([@b25-cia-3-431]; [@b55-cia-3-431]; [@b101-cia-3-431]; [@b158-cia-3-431]). Thus, the favorable effects of FTIs raise the question whether an FTI might improve disease phenotypes in HGPS ([@b185-cia-3-431]). It is also important to define the extent to which these abnormalities are affected by an FTI and to determine whether FTIs will be a useful therapy in children with HGPS. A recent study found that treatment of patient's cells with an FTI did not result in a reduction in DNA DSBs and damage checkpoint signaling, although it significantly reversed the aberrant shape of their nuclei ([@b93-cia-3-431]), suggesting that DNA damage accumulation and aberrant nuclear morphology are independent phenotypes arising from prelamin A accumulation in these PSs. [@b182-cia-3-431] created gene-targeted mice with an HGPS mutation (LmnaHG/+) and examined the effect of an FTI on the disease phenotypes. The LmnaHG/+ mice exhibited phenotypes similar to those in human HGPS patients, including retarded growth, reduced amounts of adipose tissue, micrognathia, osteoporosis, and osteolytic lesions in bone. In addition, osteolytic lesions in the ribs led to spontaneous bone fractures. Treatment with an FTI ameliorated the disease phenotypes, resulting in an increased adipose tissue mass, improved body weight curves, a reduction in the number of rib fractures, and improved bone mineralization and bone cortical thickness, suggesting that FTIs could be useful for treating HGPS patients ([@b182-cia-3-431]). Though FTIs fall short of curing the disease ([@b182-cia-3-431]), these findings have established a paradigm for ameliorating the most obvious cellular pathology in HGPS and suggest a potential strategy for treating this disease.

A hypothetical model of aging
=============================

The molecular mechanisms involved in human senescence are complicated. Two canonical PSs, WS and HGPS, characterized by clinical features mimicking physiological aging at an early age, have provided insights into the mechanisms of natural aging. In these PSs, several cellular pathways are affected, resulting in the formation of endogenous and exogenous sources of oxidative stress, telomere attrition, and a decline in DNA repair, which can jointly contribute to genomic instability, and subsequently result in growth arrest and apoptosis, leading to the human aging phenotypes ([@b79-cia-3-431]; [@b129-cia-3-431]; [@b32-cia-3-431]). The gene defective in WS, *WRN*, encodes a helicase of the RecQ family and possesses an exonuclease domain. WRN is involves in multiple DNA repair pathways and plays a significant role in the maintenance of overall genomic stability ([@b5-cia-3-431]) (as seen in WS). The clinical features of HGPS show similarities to WS, but progress more rapidly ([@b69-cia-3-431]). *LMNA*, the gene defective in HGPS, affects the structure or post-translational maturation of lamin A, a major nuclear component ([@b48-cia-3-431]). Recently, several studies have established a functional link between DNA repair and A-type lamin-associated syndromes, which are associated with transcriptional alterations, abnormal DNA replication, changed organization of higher order chromatin structure, and genomic instability ([@b138-cia-3-431]), suggesting a link between these syndromes and physiological aging (as seen in HGPS). DNA damage is generated throughout life and causes continuous damage to the macromolecular components of cells. Importantly, the rate of DNA damage production increases with ageing ([@b67-cia-3-431]; [@b138-cia-3-431]).

Thus, the causal relationship between the DNA damage response and cellular senescence suggests that DNA damage-initiated genomic instability can induce human aging phenotypes ([@b64-cia-3-431]). p53-mediated senescence and apoptosis in response to DNA damage also probably contribute to aging. Indeed, p53, as a master integrator of cellular stress, is able to respond to a wide range of DNA damage ([@b72-cia-3-431]), then, if the stress persists, prevent propagation of the damaged cells (by apoptosis or senescence) ([@b167-cia-3-431]). Following DNA damage, activation of p53 leads to transcription and upregulation of p53 target genes, among which P21 acts as the major effector of p53-induced cellular senescence. P21 levels increase gradually as cells pass into senescence ([@b3-cia-3-431]). Collectively, these results suggest that p53 activation is at least partially responsible for the induction of cellular senescence in response to DNA damage. On the other hand, various lines of evidence have shown that telomere shortening and dysfunction can also trigger DNA damage responses and are sufficient to induce cellular senescence (d'Adda [@b40-cia-3-431]; [@b155-cia-3-431]; [@b26-cia-3-431]; [@b45-cia-3-431]). Some HGP fibroblasts also appear refractory to telomerase-mediated immortalization ([@b168-cia-3-431]), and most cultures show elevated apoptosis and senescence ([@b16-cia-3-431]). Numerous studies indicate that, in the setting of *WRN* deficiency, dysfunctional telomeres trigger the onset of premature aging phenotypes, suggesting a link between increased telomere dysfunction and the genomic instability associated with the aging process (d'Adda [@b40-cia-3-431]; [@b155-cia-3-431]; [@b145-cia-3-431]; [@b26-cia-3-431]; [@b45-cia-3-431]). On the basis of the information available for WS and HGPS, we suggest a model of human aging ([Figure 1](#f1-cia-3-431){ref-type="fig"}). Human aging can be triggered by two main mechanisms, telomere shortening and DNA damage. In telomere-dependent aging, telomere shortening and dysfunction can lead to DNA damage responses, inducing cellular senescence. In DNA damage-initiated aging, DNA damage accumulates, along with DNA repair deficiencies, resulting in genomic instability and accelerated cellular senescence. Both aging mechanisms depend strongly on p53 status. These two mechanisms can act cooperatively to increase the overall level of genomic instability and trigger the onset of human aging phenotypes.
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![A hypothetical model: Genomic instability plays a central role during the aging process, triggered by two main stimuli, telomere shortening and DNA damage. (1) Telomere-dependent aging: Telomeres are essential for chromosomal stability. Telomere shortening and dysfunction can trigger DNA damage responses and are sufficient to induce cellular senescence. (2) DNA damage-initiated aging: DNA damage accumulates, along with DNA repair deficiencies, resulting in genomic instability and accelerated cellular senescence. Both mechanisms depend strongly on p53. These two mechanisms can act cooperatively to increase the overall level of genomic instability and trigger the onset of human aging phenotypes.](cia-3-431f1){#f1-cia-3-431}
